Share Article

ReportsnReports.com adds new market research report on Healthcare, Regulatory and Reimbursement Landscape in Netherlands, Nigeria, Saudi Arabia and UAE to its store.

Dallas, Texas (PRWEB)November 24, 2012

These reports are an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in Netherlands, Nigeria, Saudi Arabia and United Arab Emirates. They identify key trends in the healthcare market and provide insights into the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

The positive trends in the healthcare market can be attributed primarily to –

An increasing elderly population

Universal healthcare insurance

A high degree of access to healthcare facilities

Healthcare, Regulatory and Reimbursement Landscape - The NetherlandsThe country’s pharmaceutical market was valued at $6.6 billion in 2010 and is expected to reach approximately $9.4 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 3.7%. The medical device market size was approximately $3.1 billion in 2011 and is expected to reach approximately $4.6 billion by 2020, with a projected CAGR of 4.8%.

Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The major players covered for the pharmaceutical market are Pfizer, Merck, GlaxoSmithKline (GSK), Royal DSM, and Qiagen. The major players covered for the medical device market are Medronic, Siemens Healthcare, F. Hoffmann-La Roche, Essilor International, and Abbott Labolatories.

Healthcare, Regulatory and Reimbursement Landscape - United Arab EmiratesIn 2011, the UAE population was 8.4 million which was mainly due to the increasing number of immigration in the country. In 2011, the pharmaceutical market was estimated at $1.9 billion and is expected to reach $3.7 billion by 2020 at a projected CAGR of 7%. The medical device market was worth approximately $670.7m in 2011 and is expected to reach $979m by 2020 at a projected CAGR of 4%.

Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are Julphar, Neopharma, GlaxoSmithKline, Pfizer, and Novartis, and the key players covered for the medical device market are F. Hoffmann-La Roche Ltd, Siemens Healthcare, Medtronic, Boston Scientific Corporation Inc and Abbott Laboratories.

Healthcare, Regulatory and Reimbursement Landscape - Saudi ArabiaThe value of the pharmaceutical market was estimated at $3.5 billion in 2011, and is expected to reach $5.6 billion by 2020, increasing at a projected Compound Annual Growth Rate (CAGR) of 5.4%. The medical device market was worth approximately $1.5 billion in 2011, and is expected to reach $2.3 billion by 2020, increasing at a projected CAGR of 4.5%.

Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline (GSK), Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Pfizer, Tabuk, and Novartis; the key players covered for the medical device market are Siemens Healthcare, F. Hoffmann-La Roche, GE Healthcare, Abbott Laboratories, and Philips Healthcare.

Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline, May and Baker Nigeria, Fidson Healthcare Plc, Emzor Pharmaceuticals Industries Ltd and Evans Medical Plc.